Back to Journals » Neuropsychiatric Disease and Treatment » Volume 6 » Issue 1

Review

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients

      
Total article views   HTML views PDF downloads Totals
18,114 Dovepress* 14,111+ 2,453 16,564
PubMed Central* 4,003 806 4,809
Totals 18,114 3,259 21,373
*Since 10 November 2010
+Since July 2016

View citations on PubMed Central and Google Scholar